Clarus Therapeutics Holdings, Inc.

Headquarters: Northbrook, IL, United States

CEO: Dr. Robert E. Dudley Ph.D.

NASDAQ: CRXT -19.54%

Detailed Description

Clarus Therapeutics Holdings, Inc. operates as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy in the United States. It offers JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company has a licensing agreement with HavaH Therapeutics for product to treat androgen-dependent inflammatory breast disease and certain forms of breast cancer. Clarus Therapeutics Holdings, Inc. was founded in 2003 and is based in Northbrook, Illinois.

Top 1-year algo backtest: +313.24%

$10,000 in May 2023 would now be $41,324 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

Clarus Therapeutics Holdings, Inc. has the following listings and related stock indices.

Stock: NASDAQ: CRXT wb_incandescent



555 Skokie Boulevard

Suite 340

Northbrook, IL 60062

United States

Phone: 847 562 4300

Fax: 847 562 4306